Sensei Biotherapeutics, Inc. (NASDAQ:FTH) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Sensei Biotherapeutics, Inc. (NASDAQ:FTH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the fifteen research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, eleven have given a buy recommendation and […]
2 Oct 09:59 · The Markets Daily